Palo Alto Investors LP
Q3 2025 13F Holdings
- Locationpalo alto, CA
- Num holdings
44
- Value ($000)
$540,390
- Date Filed11/14/2025
- Form type13F-HR
- CIK0001306923
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
INSM INSMED INC | COM | 457669307 | $70.82 M | 13 % | 491,805 | ||
PTCT PTC THERAPEUTICS INC | COM | 69366J200 | $52.94 M | 10 % | 862,613 | ||
ACAD ACADIA PHARMACEUTICALS INC | COM | 004225108 | $52.64 M | 10 % | 2,466,684 | ||
FOLD AMICUS THERAPEUTICS INC | COM | 03152W109 | $42.30 M | 8 % | 5,367,798 | ||
BMRN BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | $40.84 M | 8 % | 754,007 | ||
BIIB BIOGEN INC | SPONSORED ADS | 09062X103 | $26.01 M | 5 % | 185,661 | ||
UTH UNITED THERAPEUTICS CORP | COM | 91307C102 | $24.39 M | 5 % | 58,186 | ||
ANAB ANAPTYSBIO INC | COM | 032724106 | $20.62 M | 4 % | 673,520 | ||
IOVA IOVANCE BIOTHERAPEUTICS INC | COM NEW | 462260100 | $16.53 M | 3 % | 7,618,132 | ||
NOVOCURE LTD | COM | G6674U108 | $16.23 M | 3 % | 1,256,159 |
Rows Per Page
10
- 10
- 50
- 100